A detailed history of Mather Group, Llc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 30 shares of MEDP stock, worth $10,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 48 37.5%
Holding current value
$10,454
Previous $19,000 47.37%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$320.58 - $457.29 $5,770 - $8,231
-18 Reduced 37.5%
30 $10,000
Q2 2024

Jul 08, 2024

SELL
$372.0 - $424.34 $7,812 - $8,911
-21 Reduced 30.43%
48 $19,000
Q1 2024

Apr 08, 2024

BUY
$284.87 - $413.31 $19,656 - $28,518
69 New
69 $27,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.